Saturday, November 2, 2024
Home Tags Drug development

drug development Related News

Fibrinolytic therapy: discover the blood thinning medication

Fibrinolytic therapy: discover the blood thinning medication

According to research presented at the American College of Cardiology’s 68th Annual Scientific Session, a new blood thinning medication could be effective in fibrinolytic...
CBD products: the goods in legal limbo and in high demand

CBD products: the goods in legal limbo and in high demand

Cura Partners, Inc. is a US-based company expanding into international markets with its brand of CBD products Select CBD, and this is part of...
An introduction to Columbia Care: a world-class medical cannabis business

An introduction to Columbia Care: a world-class medical cannabis business

Its unparalleled cannabis-based products and ongoing commitment to rigorous scientific research make Columbia Care LLC a world leader in medical cannabis. CEO Nicholas Vita talks...
Let’s talk medical cannabis with Sigma Analytical Services

Let’s talk medical cannabis with Sigma Analytical Services

As legalisation of medical cannabis and cannabis-derived products expands globally, Sigma Analytical Services is establishing itself as a pioneer. Understanding the complex chemistry of cannabis...
Systemic corticosteroids: can severe asthma patients benefit from this?

Systemic corticosteroids: can severe asthma patients benefit from this?

Physicians may have discovered a way to predict which patients with severe asthma are likely to benefit from treatment with systemic corticosteroids. With the help...
Could there be a new treatment for ovarian cancer?

Could there be a new treatment for ovarian cancer?

According to scientists from the University of Sheffield, UK, a drug compound could be a new treatment for ovarian cancer. Typically, chemotherapy is still the...
Did you know drug combination could treat advanced kidney cancer?

Did you know drug combination could treat advanced kidney cancer?

According to researchers from Dana-Farber Cancer Institute, USA, a drug combination could potentially become the first-line treatment for patients with advanced kidney cancer. Patients who...
Cannabis-based medicine to be tested in Azheimer’s trial

Cannabis-based medicine to be tested in Azheimer’s trial

Alzheimer’s Research UK is committing nearly £300,000 (~€341,000) for a landmark phase II clinical trial of Sativex®, a cannabis-based medicine licensed in the UK. The...
The New Modalities Ecosystem: a much-needed boost for rare diseases

The New Modalities Ecosystem: a much-needed boost for rare diseases

The collaborative New Modalities Ecosystem unites academia, pharma and technology companies to drive real and meaningful progress in research and treatments for rare diseases. IN...
Patient groups: our strongest weapon against rare diseases

Patient groups: our strongest weapon against rare diseases

Findacure CEO Rick Thompson sets out the crucial role of patient groups in developing new treatments for rare diseases. Rare diseases are defined in Europe...
How to deal with the medical cannabis dilemma

How to deal with the medical cannabis dilemma

Dr Franjo Grotenhermen, the executive director of the International Association for Cannabinoid Medicines, reflects on the legal challenges around medical cannabis. There is a general...
Medical Cannabis Medicinal

TILRAY: the medical cannabis research global leader

Medical cannabis is rapidly gaining momentum across the globe, and Tilray Inc. is pioneering the production, research, and distribution of medical cannabis. This ebook explores...
Rare blood disorders: could sutimlimab treat the untreatable?

Rare blood disorders: could sutimlimab treat the untreatable?

Researchers yearn to treat rare blood disorders, and now they may have found the solution with the investigational drug, sutimlimab. Sutimlimab has shown promising results...
Could llama blood be the unlikely ally in producing antibody therapeutics?

Could llama blood be the unlikely ally in producing antibody therapeutics?

Researchers have used llamas to produce new antibody therapeutics with the potential to work against all types of flu, including new pandemics. After testing 60...
The growth of medical cannabis in Europe

The growth of medical cannabis in Europe

Stephen Murphy, the co-founder and managing director of Prohibition Partners, shares his thoughts on the evolving landscape of medical cannabis in Europe and looks...
EU-OPENSCREEN: research infrastructure and medicinal chemistry

EU-OPENSCREEN: research infrastructure and medicinal chemistry

Dr Wolfgang Fecke introduces EU-OPENSCREEN, a European Research Infrastructure Consortium for medicinal chemistry, supporting research and its translation to medicine and agriculture. The systematic screening...
Michael Lisanti and antibiotics: the next cancer revolution

Michael Lisanti and antibiotics: the next cancer revolution

Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer. How would you cure...
From highly priced medicines to Medicines That Matter

From highly priced medicines to Medicines That Matter

Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
BioBlocks, Inc. are changing the game of drug discovery

BioBlocks, Inc.: Transforming the process of lead discovery

BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches. BioBlocks is a medicinal...
Open Targets – transforming drug discovery

Open Targets – transforming drug discovery

Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...

Pin It on Pinterest